CliffBio
small molecule

PERFOROMIST

FORMOTEROL FUMARATE

Loss of exclusivity—loss of exclusivity
CompanyVIATRIS SPECIALITY LLC

Drug detail

Brand namePERFOROMIST
Active ingredientFORMOTEROL FUMARATE
Strength0.02MG/2ML
Dosage formSOLUTION
RouteINHALATION
ModalitySmall molecule
FDA approvalMay 2007
Marketing statusRX

More from VIATRIS SPECIALITY LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.